Disruptions in m6A regulation are closely associated with the initiation and progression of cancer by modulating oncogenic signaling pathways, such as Wnt/β-catenin, MAPK, JAK/STAT, PI3K/Akt, and p53 [74], or remodeling the tumor immune microenvironment [75]. The gene discussed is AKT1; the disease is neoplasm.